She graduated as a molecular biologist and took a degree of special translator in English at the University of Debrecen in 2000. From 2002, as a PhD fellow at the Semmelweis University, she had carried out research in the field of signal transduction therapy with protein kinase inhibitors in the Laboratory of Racional Drug Design, CRC. Between 2005 and 2007, she continued her research work as a Research Assistant at the Semmelweis University. In 2009, she got her PhD degree and joined KPS Ltd. as a Researcher/Developer to participate in setting up next generation sequencing technology. Since the end of 2009, she is the leader of the diagnostic laboratory and conducts the molecular diagnostic tests predicting efficacy of new tumor therapies.